ACTRIMS Investor Call
Sanofi was pleased to invite investors and analysts to participate in a live webcast discussing tolebrutinib data presented during the ACTRIMS scientific program (February 24-26, 2022).
(16h00 CET / 10:00am EST)
Featuring
Dietmar Berger
Global Head of Development,
Tom Snow
Global Franchise Head, Neurology
Erik Wallstroem
Therapeutic Area Head, Multiple Sclerosis
Anthony Traboulsee
Professor and Research Chair of the MS Society of Canada at the University of British
Tim Turner
Global Project Head, Neurology